Search

everythinglearnresearchcommunity

for

Search:↓

The nucleus is key in controlling skin growth and repair by coordinating signals, gene regulators, and epigenetic changes.

The guidelines suggest lifestyle changes, diet adjustments, and personalized medication to manage dyslipidemia and reduce heart disease risk.

Pantethine may boost the immune system's ability to fight sarcoma.

Studying premature aging syndromes helps understand human aging and suggests potential treatments.

Certain gene variants may raise the risk of prostate enlargement, but taking NSAIDs could reduce this risk.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.

Inhibiting ODC can prevent UV-induced skin cancer.

Androgens are important for female fertility and could help in IVF treatment, but also play a role in causing PCOS.

Eupafolin nanoparticles help protect skin cells from damage caused by air pollution.

Stopping mitochondrial respiration can prevent brain cancer spread in skin cancer patients, and plant compound β-sitosterol could help achieve this.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Leptin-deficient mice, used as a model for Type 2 Diabetes, have delayed wound healing due to impaired contraction and other dysfunctional cellular responses.

Prostaglandins and the enzyme AKR1C3 could play a role in skin cancer and hair loss, and further research is needed to understand these mechanisms.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

Combination pharmacotherapy is generally more effective for treating keloids and hypertrophic scars.

Effective treatment guidelines for frontal fibrosing alopecia are still unclear.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

Brain-made chemicals can control nerve cell function differently in various parts of a mouse's brain, which may help us understand neurological conditions.

Cyclooxygenase-2 overexpression in mice skin causes hair loss like human androgenetic alopecia.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

Antiandrogen therapy helps treat genetic hair loss.

The conclusion is that more hair loss (androgenetic alopecia) is linked to larger prostate size, suggesting hair loss could be an early sign of benign prostatic hyperplasia.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

New understanding and treatments for hair loss are improving, but more research is needed.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.